Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
473815
Created by
admin on Mon Mar 31 23:22:18 GMT 2025 , Edited by admin on Mon Mar 31 23:22:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
571045EIM4
Created by
admin on Mon Mar 31 23:22:18 GMT 2025 , Edited by admin on Mon Mar 31 23:22:18 GMT 2025
|
PRIMARY | |||
|
EF-49
Created by
admin on Mon Mar 31 23:22:18 GMT 2025 , Edited by admin on Mon Mar 31 23:22:18 GMT 2025
|
PRIMARY | |||
|
1518996-49-0
Created by
admin on Mon Mar 31 23:22:18 GMT 2025 , Edited by admin on Mon Mar 31 23:22:18 GMT 2025
|
PRIMARY | |||
|
DB12296
Created by
admin on Mon Mar 31 23:22:18 GMT 2025 , Edited by admin on Mon Mar 31 23:22:18 GMT 2025
|
PRIMARY | |||
|
Andecaliximab
Created by
admin on Mon Mar 31 23:22:18 GMT 2025 , Edited by admin on Mon Mar 31 23:22:18 GMT 2025
|
PRIMARY | |||
|
C105803
Created by
admin on Mon Mar 31 23:22:18 GMT 2025 , Edited by admin on Mon Mar 31 23:22:18 GMT 2025
|
PRIMARY | |||
|
10035
Created by
admin on Mon Mar 31 23:22:18 GMT 2025 , Edited by admin on Mon Mar 31 23:22:18 GMT 2025
|
PRIMARY | |||
|
100000172779
Created by
admin on Mon Mar 31 23:22:18 GMT 2025 , Edited by admin on Mon Mar 31 23:22:18 GMT 2025
|
PRIMARY |
ACTIVE MOIETY